White & Case advises Summit Partners on investment in Dreampath Diagnostics

Global law firm White & Case LLP has advised leading growth-focused investment firm Summit Partners on its investment in Dreampath Diagnostics.

The investment will support the company's plans to accelerate global growth, scale operations and expand its commercial reach and product portfolio. As part of the transaction, two members of the Summit Partners team will join the Dreampath Diagnostics Board of Directors.

Dreampath Diagnostics is a global leader in digital sample management systems for anatomical pathology laboratories.

The White & Case team which advised on the transaction was led by partner Guillaume Vitrich (Paris) and included partners Alexandre Jaurett, Clara Hainsdorf, Orion Berg, Quirec de Kersauson, Brice Engel, Kami Haeri (all Paris), Hope Anderson (Los Angeles), David Bond, Farhad Jalinous (both Washington, DC), Jaye Kasper, Bethany Hills, Tal Marnin, Sasha Belinkie, Scott Fryman (all New York), Carlos Daroca (Madrid) and Alan Bao (Beijing), counsel Amanda Woodall (Houston), Katrin Helle (Berlin), Annie Anderson, Heidi Schmid (both New York) and Chris Thomas (London) and associates Nicolas Alfonsi, Marco Hladík, Matthieu Shamloo, Sarah Kouchad, Hovig Cancioglu, Olga Kosno, Louis Roussier, Pauline Abbouche, Grégoire Baudry, Clément Bellaclas, Mathilde Bernier, Dylan Deligny (all Paris), Benedict Tansey, Kyle Spencer, Alec Buchanan, Amanda Kingsley, Sam Ahmad (all London), Edward Ernst (New York), Allison Kepkay, Timothy Sensenig (both Washington, DC), Lucee Laursen (Chicago), Zixie Zhu (Beijing), Qianru Hong (Shanghai) and Joao Lacerda (London & Brussels).

Press contact
For more information please speak to your local media contact.